We found that IL‐17 promoted cell growth of GBM cells and obviously increased the protein expressions of CDK4 and Cyclin D. Then, we explored the underlying signalling pathway regarding IL‐17A function as a pro‐metastatic and pro‐proliferative factor. This evidence concerns the gene CDK4 and glioblastoma.